|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01332 TOUYUN BIOTECH
Nominal 
0.157 +0.002 (+1.290%) | 2026/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2025/06 HKD(K$) | 2024/06 HKD(K$) | 2023/06 HKD(K$) | 2022/06 HKD(K$) | |
| Turnover | 35,389 | -3.259% | 36,581 | 73,047 | 104,345 | 166,063 |
| Cost of Sales | (26,273) | 14.067% | (23,033) | (41,108) | (68,437) | (107,725) |
| Gross Profit | 9,116 | -32.713% | 13,548 | 31,939 | 35,908 | 58,338 |
| 2026/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2025/06 HKD(K$) | 2024/06 HKD(K$) | 2023/06 HKD(K$) | 2022/06 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 310,815 | 758.676% | 36,197 | (49,145) | (85,081) | (86,308) | |
| Taxation | (18) | 63.636% | (11) | 326 | (22) | (1,950) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | (8,132) | -- | -- | -- | |
| Non-controlling Interests | (112,949) | 571.876% | (16,811) | 850 | 1,152 | 192 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 197,848 | 1659.744% | 11,243 | (47,969) | (83,951) | (88,066) | |
| 2026/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2025/06 HKD(K$) | 2024/06 HKD(K$) | 2023/06 HKD(K$) | 2022/06 HKD(K$) | |
| Net Finance Costs / (Income) | 15,279 | 250.999% | 4,353 | 4,424 | 4,096 | 20,658 |
| Depreciation & Amortisation | 10,393 | -3.294% | 10,747 | 17,148 | 19,180 | 13,163 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/06 | 2024/06 | 2023/06 | 2022/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/06 | 2024/06 | 2023/06 | 2022/06 | |
| EPS (cts) | 7.050 | 1662.500% | 0.400 | -1.710 | -2.990 | -3.140 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 0.050 | -- | (0.023) | (0.017) | 0.066 | 0.137 |
| Remarks: | Real time quote last updated: 11/09/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD 197,848 |
| %Change | 1659.744% |
| EPS / (LPS) | HKD 0.071 |
| NBV Per Share ($) | HKD 0.050 |